All USA & Canada articles – Page 56
-
NewsProgram receives grant to study causes of death in adults with HIV in Africa
A new grant will allow the CHAMPS network to leverage its laboratory capacity and partnerships in Africa to identify and document causes of death among adults who were living with HIV.
-
NewsResearchers produce guidelines to tackle science’s ‘AI problem’
With growing evidence revealing deep flaws in how machine learning is used in science, an interdisciplinary team of 19 researchers has published guidelines for the responsible use of AI in science.
-
NewsHow does bird flu infect so many species?
Reports of the first documented case of the H5N1 virus passing from birds to cows — and then from a cow to a person - have generated a lot of concern over diseases ‘spilling over’ from wildlife to livestock and humans.
-
NewsNew strategy could lead to universal, long-lasting flu shot
Researchers have opened a new avenue in the attack against influenza viruses by creating a vaccine that encourages the immune system to target a portion of the virus surface that is less variable.
-
NewsClosing the U.S./Mexico border during COVID-19 increased HIV transmission
When the border crossing separating San Diego, California, from Tijuana, Mexico, was closed during the COVID-19 pandemic, drug tourism from San Diego to Tijuana continued, providing a flow of people in both directions.
-
NewsGroundbreaking clinical trial evaluates oncolytic virus for non-small cell lung cancer
Moffitt Cancer Center has launched a pioneering clinical trial for patients with late-stage non-small cell lung cancer, using a novel oncolytic virus, MEM-288, in combination with the immune checkpoint inhibitor nivolumab.
-
NewsCelebrity weight-loss drug helps people with HIV fight fatty liver, study shows
Scientists have found that a medication used to treat diabetes and obesity – and touted on social media for weight loss – can be a powerful weapon against a type of fatty liver disease in people with HIV.
-
NewsPioneering oral fungal infection treatment shows promise in preclinical trials
A novel oral amphotericin B (MAT2203) developed for treatment of invasive mucormycosis (IM) and other deadly invasive fungal infections, has demonstrated encouraging results in a series of preclinical studies.
-
NewsBiodegradable ‘living plastic’ houses bacterial spores that help it break down
Researchers have developed a biodegradable form of thermoplastic polyurethane (TPU), filled with bacterial spores that, when exposed to nutrients present in compost, germinate and break down the material at the end of its life cycle.
-
NewsA significant portion of the world’s population continues to trust vaccines, says survey in 23 countries
A substantial proportion of the world’s population remains willing to get vaccinated against diseases including COVID-19, according to a new survey across 23 countries that represent more than 60% of the world’s population.
-
NewsStaying current with COVID-19 vaccinations helps combat emerging variants
The study is among the first to test in a biosafety level 3 laboratory whether vaccine-elicited antibodies block infection of a live virus.
-
NewsFlorida dolphin found with highly pathogenic avian flu
The case of a Florida bottlenose dolphin found with highly pathogenic avian influenza virus, or HPAIV — a discovery made by University of Florida researchers in collaboration with multiple other agencies and one of the first reports of a constantly growing list of mammals affected by this virus — has ...
-
NewsUndocumented Latinx patients got COVID-19 vaccine at same rate as US citizens
For undocumented Latinx patients who sought care in the emergency room during the pandemic, the reported rate of having received the COVID-19 vaccine was found to be the same as U.S. citizens, a new UCLA Health study has found. These findings surprised researchers, given that COVID-19 disproportionately affected the Latinx ...
-
NewsStudy details a common bacterial defense against viral infection
One of the many secrets to bacteria’s success is their ability to defend themselves from viruses, called phages, that infect bacteria and use their cellular machinery to make copies of themselves. Source: Mogana Das Murtey and Patchamuthu Ramasamy Bacillus cereus, SEM image Technological advances have enabled recent ...
-
NewsBioinformatics professor discovers surprising evolutionary pattern in landmark yeast study
A new study challenges accepted frameworks within which yeast evolution is studied and provide access to an incredibly rich yeast analysis dataset that could have major implications for future evolutionary biology and bioinformatics research.
-
NewsNew tool helps identify babies at high risk for RSV
A new tool to identify infants most at risk for severe respiratory syncytial virus (RSV) illness could aid pediatricians in prioritizing children under 1 to receive a preventive medication before RSV season (October-April).
-
NewsChlamydia and gonorrhea more likely to be treated per CDC guidelines in males, younger patients and those identifying as Black or multiracial
A recent study of individuals ages 15 to 60 has found that nearly one in five patients with chlamydia and one in four patients with gonorrhea did not receive CDC recommended treatment for their infection.
-
NewsLower dose of mpox vaccine is safe and generates six-week antibody response equivalent to standard regimen
A dose-sparing intradermal mpox vaccination regimen was safe and generated an antibody response equivalent to that induced by the standard regimen at six weeks (two weeks after the second dose), according to new findings.
-
NewsThe rise of microbial cheaters in iron-limited environments
Competition and cooperation are fundamental forces that govern the evolutionary and ecological dynamics among species. The balance between these forces varies across ecological contexts, with some environments favoring cooperative behaviors that promote mutual benefit, while others reward competitive strategies that maximize individual fitness. Among microbial communities, chemicals ...
-
NewsStudy confirms effectiveness of bivalent COVID-19 vaccine
A major bivalent COVID-19 vaccine induces production of neutralizing antibodies against the coronavirus that circulated at the start of the pandemic as well as subvariants of omicron, albeit less abundantly, according to a new study.